Catalyst Wire Dossier Catalyst Wire Dossier

Seretide Diskus 500 mcg inhalation powder

salmeterol/fluticasone
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Seretide Diskus 500 mcg inhalation powder, covering 2022-05-20 to 2022-05-20. Get the full timeline:

Most recent: Clinical Trial Update: Salmeterol/Fluticasone 50/500 mcg Inhalation Powder Via Capsair vs Seretide Diskus 500 mcg Inhalation Powder in Patients With COPD [Phase 4]

See pricing